Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Results Availability and Timeliness of Registered COVID-19 Clinical Trials: A Cross-Sectional Study

View ORCID ProfileMaia Salholz-Hillel, View ORCID ProfilePeter Grabitz, Molly Pugh-Jones, View ORCID ProfileDaniel Strech, View ORCID ProfileNicholas J. DeVito
doi: https://doi.org/10.1101/2021.04.07.21255071
Maia Salholz-Hillel
1QUEST Center for Transforming Biomedical Research, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maia Salholz-Hillel
Peter Grabitz
1QUEST Center for Transforming Biomedical Research, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Grabitz
Molly Pugh-Jones
1QUEST Center for Transforming Biomedical Research, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Strech
1QUEST Center for Transforming Biomedical Research, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Strech
Nicholas J. DeVito
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Rd., Oxford, OX2 6GG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas J. DeVito
  • For correspondence: nicholas.devito{at}phc.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To examine how and when the results of COVID-19 clinical trials are disseminated.

Design Cross-sectional bibliographic study

Setting The COVID-19 clinical trial landscape

Participants 285 registered interventional clinical trials for the treatment and prevention of COVID-19 completed by 30 June 2020

Main outcome measures Overall reporting and reporting by dissemination route (i.e., by journal article, preprint, or results on a registry); time to reporting by dissemination route.

Results Following automated and manual searches of the COVID-19 literature, we located 41 trials (14%) with results spread across 47 individual results publications published by 15 August 2020. The most common dissemination route was preprints (n = 25) followed by journal articles (n = 18), and results on a registry (n = 2). Of these, four trials were available as both a preprint and journal publication. The cumulative incidence of any reporting surpassed 20% at 119 days from completion. Sensitivity analyses using alternate dates available and definitions of results did not appreciably change the reporting percentage. Expanding minimum follow-up time to 3 months increased the overall reporting percentage to 19%.

Conclusion COVID-19 trials completed during the first six months of the pandemic did not consistently yield rapid results in the literature or on clinical trial registries. Our findings suggest that the COVID-19 response may be seeing quicker results disclosure compared to non-emergency conditions. Issues with the reliability and timeliness of trial registration data may impact our estimates. Ensuring registry data is accurate should be a priority for the research community during a pandemic. Data collection is underway for Phase 2 of the DIRECCT study expanding our trial population to those completed anytime in 2020.

Competing Interest Statement

All authors declare that they have no direct conflict of interest related to this work. Outside of the submitted work, NJD has received a doctoral studentship from the Naji Foundation, grant support from the Fetzer-Franklin Memorial Fund, and been employed on a grant from the Laura and John Arnold Foundation. MSH is employed as a researcher under additional grants from the German Bundesministerium für Bildung und Forschung (BMBF). PG received grant funding from the BMBF and Mercator Foundation and consults for scite inc. MPJ received grant funding from the BMBF. DS serves as a member of the Sanofi Advisory Bioethics Committee and receives an honorarium for contributing to meetings.

Clinical Trial

This study was preregistered on the OSF: https://osf.io/8fr9t

Funding Statement

The CEOsys project is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin - NUM) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung - BMBF). FKZ: 01KX2021. During the course of this project NJD was also employed on a grant from The Good Thinking Society to work on trials transparency research. The funders had no involvement in the study design, analysis, or writing of the manuscript nor the decision to submit.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was exempted from ethics approval at the University of Oxford as it solely used non-disclosive, publicly available data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All code for this project is available at https://github.com/ebmdatalab/covid19_results_reporting and https://github.com/maia-sh/direcct. The full dataset is available at https://www.doi.org/10.5281/zenodo.4669937.

https://github.com/ebmdatalab/covid19_results_reporting

https://github.com/maia-sh/direcct

https://www.doi.org/10.5281/zenodo.4669937

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Results Availability and Timeliness of Registered COVID-19 Clinical Trials: A Cross-Sectional Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Results Availability and Timeliness of Registered COVID-19 Clinical Trials: A Cross-Sectional Study
Maia Salholz-Hillel, Peter Grabitz, Molly Pugh-Jones, Daniel Strech, Nicholas J. DeVito
medRxiv 2021.04.07.21255071; doi: https://doi.org/10.1101/2021.04.07.21255071
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Results Availability and Timeliness of Registered COVID-19 Clinical Trials: A Cross-Sectional Study
Maia Salholz-Hillel, Peter Grabitz, Molly Pugh-Jones, Daniel Strech, Nicholas J. DeVito
medRxiv 2021.04.07.21255071; doi: https://doi.org/10.1101/2021.04.07.21255071

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Medical Ethics
Subject Areas
All Articles
  • Addiction Medicine (428)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3286)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13349)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5140)
  • Geriatric Medicine (481)
  • Health Economics (781)
  • Health Informatics (3261)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14618)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4914)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (204)